[{"address1": "18702 North Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "425 939 7410", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 63, "title": "Chairman, President & CEO", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 1235350, "exercisedValue": 0, "unexercisedValue": 15820780}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 51, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 715350, "exercisedValue": 0, "unexercisedValue": 341880}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 49, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2024, "totalPay": 598862, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 34, "title": "Chief Financial Officer", "yearBorn": 1990, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 44, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Roee  Shahar", "title": "Executive Vice President of Commercial", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.83, "open": 8.9, "dayLow": 8.65, "dayHigh": 8.95, "regularMarketPreviousClose": 8.83, "regularMarketOpen": 8.9, "regularMarketDayLow": 8.65, "regularMarketDayHigh": 8.95, "payoutRatio": 0.0, "beta": 1.947, "forwardPE": -3.0172412, "volume": 1060095, "regularMarketVolume": 1060095, "averageVolume": 1135875, "averageVolume10days": 903790, "averageDailyVolume10Day": 903790, "bid": 8.71, "ask": 8.79, "bidSize": 1, "askSize": 1, "marketCap": 761357632, "fiftyTwoWeekLow": 5.15, "fiftyTwoWeekHigh": 16.81, "priceToSalesTrailing12Months": 69.60666, "fiftyDayAverage": 8.3707, "twoHundredDayAverage": 10.491125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 448804864, "profitMargins": 0.0, "floatShares": 69498487, "sharesOutstanding": 87012304, "sharesShort": 13239384, "sharesShortPriorMonth": 13646456, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.1522, "heldPercentInsiders": 0.11476, "heldPercentInstitutions": 0.83275, "shortRatio": 13.67, "shortPercentOfFloat": 0.15890001, "impliedSharesOutstanding": 88194800, "bookValue": 3.532, "priceToBook": 2.47735, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -205111008, "trailingEps": -3.01, "forwardEps": -2.9, "enterpriseToRevenue": 41.032, "enterpriseToEbitda": -2.554, "52WeekChange": -0.26716918, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 8.75, "targetHighPrice": 38.0, "targetLowPrice": 20.0, "targetMeanPrice": 24.5, "targetMedianPrice": 23.0, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 317323008, "totalCashPerShare": 3.647, "ebitda": -175726000, "totalDebt": 4770000, "quickRatio": 10.304, "currentRatio": 10.492, "totalRevenue": 10938000, "debtToEquity": 1.553, "revenuePerShare": 0.167, "returnOnAssets": -0.33540002, "returnOnEquity": -0.69212997, "grossProfits": -140107008, "freeCashflow": -117161872, "operatingCashflow": -152679008, "revenueGrowth": 1.844, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -15.25496, "financialCurrency": "USD", "symbol": "IMNM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "regularMarketChangePercent": -0.906001, "regularMarketPrice": 8.75, "postMarketChangePercent": 0.114288, "postMarketPrice": 8.76, "postMarketChange": 0.0100002, "regularMarketChange": -0.0799999, "regularMarketDayRange": "8.65 - 8.95", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1135875, "fiftyTwoWeekLowChange": 3.6, "fiftyTwoWeekLowChangePercent": 0.6990291, "fiftyTwoWeekRange": "5.15 - 16.81", "fiftyTwoWeekHighChange": -8.059999, "fiftyTwoWeekHighChangePercent": -0.47947648, "fiftyTwoWeekChangePercent": -26.716917, "earningsTimestamp": 1747080300, "earningsTimestampStart": 1754909940, "earningsTimestampEnd": 1755259200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -3.01, "epsForward": -2.9, "epsCurrentYear": -2.09286, "priceEpsCurrentYear": -4.1808815, "fiftyDayAverageChange": 0.37930012, "fiftyDayAverageChangePercent": 0.045312833, "twoHundredDayAverageChange": -1.7411251, "twoHundredDayAverageChangePercent": -0.16596171, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-10-02", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1750452956, "regularMarketTime": 1750449602, "exchange": "NCM", "messageBoardId": "finmb_108518404", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601645400000, "displayName": "Immunome", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]